Alkermes plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ALKS Nasdaq 2836 www.alkermes.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alkermes plc

Alkermes Showcases Research From Psychiatry and Sleep Portfolios at the Neuroscience Education Institute Fall Congress - Nov 5th, 2026 5:00 am
Alkermes (ALKS) Stock Could Be Overvalued Following ALKS 7290 Trial Launch - Nov 4th, 2026 5:15 am
Alkermes PLC (ALKS) Q3 2026 Earnings Call Highlights: Proprietary Sales Surge 31% as Orexin ... - Nov 3rd, 2026 8:04 pm
Alkermes (ALKS) Q3 2026 Earnings Call Transcript - Nov 3rd, 2026 2:28 pm
Alkermes to Present at Upcoming Investor Conferences - Nov 3rd, 2026 2:00 pm
What Alkermes (ALKS) Said on Its Q3 Earnings Call - Nov 3rd, 2026 11:14 am
Alkermes plc Q3 2026 Earnings Call Summary - Nov 3rd, 2026 10:49 am
Alkermes (ALKS) Reports Q3 Earnings: What Key Metrics Have to Say - Nov 3rd, 2026 6:30 am
Alkermes (ALKS) Surpasses Q3 Earnings and Revenue Estimates - Nov 3rd, 2026 5:15 am
Alkermes: Q3 Earnings Snapshot - Nov 3rd, 2026 5:12 am
Alkermes plc Reports Third Quarter 2026 Financial Results - Nov 3rd, 2026 5:05 am
Axsome Sinks 10% Despite Q3 Revenue Beat “Surpassing a One-Billion-Dollar Annual Run Rate” - Nov 2nd, 2026 11:56 am
Alkermes (ALKS) Starts Phase 2 MDD Trial, Is The Upside Already Priced In? - Oct 31st, 2026 12:15 am
Alkermes Expands ALKS 7290 Development Program With Initiation of Phase 2 Study for the Adjunctive Treatment of Major Depressive Disorder (MDD) - Oct 30th, 2026 5:00 am
Alnylam Pharmaceuticals (ALNY) Q3 Earnings and Revenues Top Estimates - Oct 29th, 2026 7:30 am
Earnings Preview: Tarsus Pharmaceuticals, Inc. (TARS) Q3 Earnings Expected to Decline - Oct 27th, 2026 7:00 am
Alkermes to Report Third Quarter Financial Results on November 3, 2026 - Oct 20th, 2026 2:00 pm
Earnings Preview: Alkermes (ALKS) Q3 Earnings Expected to Decline - Oct 20th, 2026 7:00 am